D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$728M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$625M |
| 3 |
Merck
MRK
|
+$498M |
| 4 |
Bank of America
BAC
|
+$487M |
| 5 |
Fortinet
FTNT
|
+$321M |
Top Sells
| 1 |
Tesla
TSLA
|
+$696M |
| 2 |
Adobe
ADBE
|
+$610M |
| 3 |
Accenture
ACN
|
+$518M |
| 4 |
Microsoft
MSFT
|
+$495M |
| 5 |
Broadcom
AVGO
|
+$471M |
Sector Composition
| 1 | Technology | 22.95% |
| 2 | Consumer Discretionary | 14.11% |
| 3 | Healthcare | 10.4% |
| 4 | Financials | 9.83% |
| 5 | Industrials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Vera Therapeutics
VERA
$1.52B
| $5.77M | 0.01% |
130,466
-240,219
| -65% | -$10.6M |
|
1102
Life Time Group Holdings
LTH
$6.29B
| $5.76M | ﹤0.01% |
235,997
+199,969
| +555% | +$4.88M |
|
1103
Packaging Corp of America
PKG
$19.4B
| $5.75M | ﹤0.01% |
26,691
+4,360
| +20% | +$939K |
|
1104
MarineMax
HZO
$556M
| $5.74M | ﹤0.01% |
162,875
+28,038
| +21% | +$989K |
|
1105
GoDaddy
GDDY
$20.1B
| $5.74M | ﹤0.01% |
36,634
+1,126
| +3% | +$177K |
|
1106
Knowles
KN
$1.9B
| $5.74M | ﹤0.01% |
318,401
-167,141
| -34% | -$3.01M |
|
1107
Monro
MNRO
$519M
| $5.73M | ﹤0.01% |
198,453
-70,101
| -26% | -$2.02M |
|
1108
Honeywell
HON
$134B
| $5.72M | ﹤0.01% |
27,695
-40,036
| -59% | -$8.28M |
|
1109
Acadia Healthcare
ACHC
$2.01B
| $5.72M | ﹤0.01% |
90,253
+57,495
| +176% | +$3.65M |
|
1110
General Dynamics
GD
$87.7B
| $5.71M | ﹤0.01% |
18,883
+16,116
| +582% | +$4.87M |
|
1111
Mr. Cooper
COOP
$14.1B
| $5.69M | ﹤0.01% |
61,700
+30,200
| +96% | +$2.78M |
|
1112
Coursera
COUR
$1.8B
| $5.69M | ﹤0.01% |
716,073
-203,826
| -22% | -$1.62M |
|
1113
Huntington Ingalls Industries
HII
$10.8B
| $5.68M | ﹤0.01% |
21,498
-2,984
| -12% | -$789K |
|
1114
Mobileye
MBLY
$11.1B
| $5.67M | ﹤0.01% |
413,713
+77,661
| +23% | +$1.06M |
|
1115
Criteo
CRTO
$1.15B
| $5.67M | ﹤0.01% |
140,805
+64,040
| +83% | +$2.58M |
|
1116
AdaptHealth
AHCO
$1.26B
| $5.65M | ﹤0.01% |
502,882
-14,934
| -3% | -$168K |
|
1117
Bandwidth Inc
BAND
$495M
| $5.65M | ﹤0.01% |
322,432
-92,964
| -22% | -$1.63M |
|
1118
BJ's Restaurants
BJRI
$684M
| $5.65M | ﹤0.01% |
173,384
+60,241
| +53% | +$1.96M |
|
1119
Banco Macro
BMA
$2.8B
| $5.63M | ﹤0.01% |
88,730
+62,271
| +235% | +$3.95M |
|
1120
Bio-Rad Laboratories Class A
BIO
$7.59B
| $5.62M | ﹤0.01% |
16,788
-26,188
| -61% | -$8.76M |
|
1121
Cognizant
CTSH
$33.8B
| $5.6M | ﹤0.01% |
72,538
-115,085
| -61% | -$8.88M |
|
1122
Novartis
NVS
$240B
| $5.57M | ﹤0.01% |
48,424
+45,588
| +1,607% | +$5.24M |
|
1123
Boston Properties
BXP
$12.2B
| $5.56M | ﹤0.01% |
69,047
-91,818
| -57% | -$7.39M |
|
1124
Yum China
YUMC
$16.1B
| $5.55M | ﹤0.01% |
123,371
+13,791
| +13% | +$621K |
|
1125
Factset
FDS
$13.7B
| $5.55M | ﹤0.01% |
12,059
-1,578
| -12% | -$726K |
|